Status:
COMPLETED
Occlusal Splint and Masticatory Muscle Injection in Myofacial Pain
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
Myofacial Pain
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Myofascial pain is one of the common symptoms in patients with temporomandibular joint disorders. Occlusal splint use, trigger point injections and the combination of this two methods are primary trea...
Detailed Description
48 patients who had myofacial pain and were diagnosed with according to Diagnostic Criteria for Temporomandibular Disorders were included in the study. There were 16 patients in each group. Group 1 wa...
Eligibility Criteria
Inclusion
- Indication of muscle pain according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) diagnostic decision tree,
- Having minimum three trigger points in the masseter muscles on palpation (active or latent),
- No medical or surgical treatment for temporomandibular joint in the last 3 months,
- No history of occlusal splint treatment,
- Not had a masticatory muscle injection or dry needling before,
- Absence of active caries and pulpal lesions,
- No missing teeth other than the third molar,
Exclusion
- Intra-Articular Disorders or Degenerative Joint Disease indication according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) diagnostic decision tree,
- Presence of active infection in the masseter trigger point area,
- Being in the mixed dentition period,
- The patient has used an occlusal splint before,
- Known allergy to local anesthetics,
- Having a needle phobia,
- Presence of congenital head and neck deformity,
- Having systemic joint disease,
- Presence of cardiovascular disease, thyroid disease, diabetes, hypertension, renal failure, isolated muscle disease, rheumatological and neurological disease,
- Having a history of trauma in the head and neck region in the last 2 years,
- Presence of malignancy or having undergone head and neck radiotherapy/chemotherapy in the last 2 years,
- Presence of bleeding disorder,
- Use of analgesic, corticosteroid and anticonvulsant drugs,
- Presence of fibromyalgia diagnosis,
- Being treated by a neurologist for neurological disorders and/or neuropathic pain and/or headache,
- Pregnancy or lactation,
- Having a known psychiatric disorder and using antidepressants in the last 6 months,
- Having drug and/or alcohol addiction,
- Being under active orthodontic treatment.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05228327
Start Date
August 1 2020
End Date
November 1 2021
Last Update
January 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medipol University Dental School
Istanbul, Unkapani, Turkey (Türkiye), 34083